A study of a breast cancer cell lines stimulated with EGF showed an increase in MMP9 but not MMP2, but this increase was not inhibited by the tyrosine kinase inhibitor PD153035 (Kondapaka et al, 1997). This evidence concerns the gene MMP9 and breast carcinoma.